Prognosis of prostate cancer depended on tumor stage, grade, pre-therapy prostate specific antigen level and Gleason score, which indicated that patients with local or regional prostate cancers had a much better survival rate than those with distant metastasis [4]. This evidence concerns the gene KLK3 and prostate cancer.